Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$5.95 - $15.79 $3,016 - $8,005
-507 Reduced 4.38%
11,065 $174,000
Q2 2023

Aug 11, 2023

BUY
$4.89 - $10.57 $56,587 - $122,316
11,572 New
11,572 $114,000
Q4 2021

Feb 16, 2022

SELL
$21.07 - $34.98 $155,644 - $258,397
-7,387 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$24.85 - $40.25 $183,566 - $297,326
7,387 New
7,387 $219,000

Others Institutions Holding ICVX

About Icosavax, Inc.


  • Ticker ICVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,885,200
  • Description
  • Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...
More about ICVX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.